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Abstract 
Enzyme-immune assays are currently the methods of choice for gluten control in foods 
labelled as “gluten free”, providing a mechanism for assessing food safety for 
consumption by coeliac and other allergic patients. However, their limitations, many of 
them associated to the reactivity of the different antibodies used and their degree of 
specificity, have prevented the establishment of a standardized method of analysis. We 
explore new methods for quantitatively determine gluten content in foods based on the 
use of two recently described aptamers, raised against a 33-mer peptide recognised as 
the immunodominant fragment from α2-gliadin. The assays use the target peptide 
immobilized onto streptavidin-coated magnetic beads in combination with a limited 
amount of biotin-aptamer in a competitive format, followed by streptavidin-peroxidase 
labelling of the aptamer that remains bound to the magnetic beads. The enzyme activity 
onto the beads, measured by chronoamperometry in disposable screen-printed 
electrodes, is inversely related to the target concentration in the test solution. We find 
that while the assay using the aptamer with the highest affinity towards the target (Gli 4) 
achieves low detection limits (~0.5 ppm) and excellent analytical performance when 
challenged in samples containing the intact protein, gliadin, it fails in detecting the 
peptide in solution. This problem is circumvented by employing another aptamer (Gli 
1), the most abundant one in the SELEX pool, as a receptor. The proposed assays allow 
the convenient detection of the allergen in different kind of food samples, including 
heat-treated and hydrolysed ones. The obtained results correlate with those of 
commercially available antibody-based assays, providing an alternative for ensuring the 
safety and quality of nominally gluten-free foods. 
Keywords: Aptamer, Coeliac disease, Electrochemical detection, Gliadin analysis, 
Gluten, 33-mer peptide.  
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1. Introduction 
Gluten detection is an outstanding problem because of its relation with coeliac disease 
(CD) and gluten-related allergies or intolerances. CD is one of the most prevalent 
autoimmune diseases affecting 1% of population and is related to genetic factors and 
triggered by the ingestion of gluten [1]. The only treatment for CD is the strict 
following of a lifelong gluten free diet. Because of the seriousness of the CD and its 
prevalence, EU legislation enforces the labelling of food that may contain gluten-
containing cereals, and allows to label as “gluten free” products those containing less 
than 20 ppm of gluten [2]. However, there is not universal agreement on what the term 
“gluten free” means. For example, Spanish Federation of CD patients Associations 
(FACE) stablishes a “Gluten Free Certification”, which assures that the product 
contains less than 10 ppm of gluten. But there are especially sensitive patients who can 
develop symptomatology after the ingestion of minimal amounts of gluten that makes 
those limits insufficient. The lowering of the existent limits is being frustrated by the 
need for more sensitive and reliable gluten detection methods to be applied in the food 
industry.  
The development of gluten detection methods has to confront some challenges because 
of the nature of the analytical problem. First, the lack of a clearly defined chemical 
target, as gluten is the popular name given to major storage proteins of certain dietary 
grains. Gliadins, the alcohol soluble fraction of wheat gluten, and homologous proteins 
in barley, rye and possibly oats, globally termed as prolamins, are the main target in 
gluten analysis. Additionally, during food processing the proteins composing gluten 
may suffer alterations induced by thermal or enzymatic treatments. Gluten proteins have 
a relatively large amount of –SH containing amino acids. These residues form 
intrachain S-S bonds that suffer different changes depending on the thermal food 
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processing. Breaking of the S-S intrachain bonds and formation of new ones between 
different chains originates a polymeric structure with low solubility, avoiding 
quantitative extraction of the proteins and affecting its further analysis [3]. The most 
common sample treatment involves extraction of gluten prolamins using a 60 % ethanol 
solution. This extraction is not capable of fully dissolving gluten in heat processed 
foods [4]. In order to overcome this problem different extraction solutions have been 
developed, incorporating a reducing reagent, for breaking interchain S-S bonds, and 
caotropic agents, to solubilize gluten proteins in the extraction solution [4,5]. The most 
used extraction mixture, called “cocktail” is composed of 2-mercaptoethanol and 
guanidine hydrochloride [5]. Another important alteration of the proteins occurs when 
food processing involves treatments in which gluten can be hydrolysed. In the 
production of starch and syrup and in brewery enzymatic processing breaks down the 
proteins into small peptides that are also toxic for CD patients [6-8]. These 
immunotoxic small peptides must also be detected to estimate the toxicity of these 
products for celiac patients. 
Enzyme-linked immunosorbent assays (ELISA) are the currently accepted methods for 
gluten determination in foods. Several antibodies targeting different fragments of gluten 
proteins are employed [9-12]. Despite their many positive characteristics, the traditional 
sandwich ELISA is not suitable for quantifying gluten in hydrolysed foods because it 
requires the presence of at least two epitopes in the target molecule, which is unlikely in 
the fragments obtained after hydrolysis. To overcome this drawback, competitive 
immunoassays have been developed based on the R5 antibody and using as calibration 
standard gliadin [4] or a mixture of whole protein and hydrolysed fragments [13] or on 
the G12 antibody and tracing the calibration curve using whole gliadin [11]. However, 
neither the sandwich assays, not the competitive ones are fully compatible with the 
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cocktail extraction solution because their components may denature the protein receptor 
[14]. A non-protein receptor for gliadin would thus contribute to the improvement of 
gluten detection methods.  
With the aim of solving this problem, we have recently obtained a panel of aptamers for 
specific binding to gliadin [15]. These non-protein receptors, obtained against one of the 
main immunogenic gluten peptides known as 33-mer [7], are able to bind not only the 
peptide used as target for selection but also the whole protein and homologous ones in 
rye, barley and oats, suggesting they might serve as viable receptors for the detection of 
gluten in foods at concentrations below the 20 ppm threshold proposed by the Codex 
Alimentarius Commission. Here, we expand this approach developing and validating 
two electrochemical competitive assays on magnetic particles for the determination of 
gluten. These assays rely on the use of two of the selected aptamers i.e. Gli 4, the ligand 
with the highest affinity towards gliadin, and Gli 1 the most abundant in the selection 
pool, whose binding to the peptide may be kinetically favoured. Their analytical 
performance is comparatively evaluated and validated against gliadin-ELISA kits. Both 
assays are complementary, proving to be reliable tools for sensitive detection of gluten 
in a wide variety of foods, including heat-treated and hydrolysed ones.  
 
2. Materials and methods 
Reagents 
DNA aptamers (5’→3’), both labelled in 5’ with biotin, 
Gli 4: (CCAGTCTCCCGTTTACCGCGCCTACACATGTCTGAATGCC) 
and Gli 1: (CTAGGCGAAATATAGCTACAACTGTCTGAAGGCACCCAAT), which 
are tagged with biotin at its 5´-terminus, were obtained from Integrated DNA 
Technologies (IDT, Leuven, Belgium). 
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Unmodified (LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF; 33-mer) and 
biotinylated (LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPFHHHHHH-lysine-
Biotin; Biotin-33-mer) peptides and QQPFP were purchased from Biomedal (Sevilla, 
Spain).  
Streptavidin modified magnetic beads with a binding capacity of 4 nmol mL-1 of free 
biotin (Dynabeads® MyOne™ streptavidin C1, 1 µm Φ, 10 mg mL-1) were provided by 
Life Technologies (Madrid, Spain). Gliadin standard solutions were prepared using the 
gliadin standard provided by the Working Group on Prolamin Analysis (PWG) and 
acquired to R-Biopharm. Streptavidin-Peroxidase conjugate (Str-HRP2, 176 units mg
-1 
peroxidase activity) was obtained from Thermo Fisher (Madrid, Spain). Reagents for 
buffer preparation, guanidinium hydrochloride, mercaptoethanol, polyvinylpyrrolidone, 
fish gelatine and enzymatic substrate 3,3′,5,5′-tetramethylbenzidine (TMB) liquid 
substrate system for ELISA were purchased from Sigma-Aldrich. Solutions were 
prepared using MilliQ purified water. 
Procedures 
Modification of streptavidin coated magnetic beads: An aliquot of 50 µL of the 
streptavidin-magnetic beads stock solution was washed twice with BLmod (1 mL PBS 
+ 0.01 % Tween-20) for 2 min and then resuspended in 1 mL of 2 µM biotinylated 33-
mer in BLmod. The tube was incubated for 30 min at 30 °C in a Thermomixer 
(Eppendorf Ibérica, Spain) under continuous shaking. After that, the beads were washed 
twice in BLmod and blocked with 500 µM biotin in BLmod for 30 min. After two new 
washing steps, they were reconstituted in 500 µL BS (50 mM TRIS pH 7.4+0.25 M 
NaCl+5 mM MgCl2) and used within the same day. 
Competitive assay: For Gli 1 assay, 30 µL of modified magnetic beads were incubated 
in 500 µL of BS with 250 nM of biotinylated aptamer and selected amounts of 
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calibration standard (or 10 µL of extracted sample) for 30 min at 30 °C in Thermomixer 
under shaking. After that, the beads were washed twice with BSL (50 mM TRIS pH 
7.4+0.25 M NaCl+5 mM MgCl2 + 0.01 % Tween-20), and incubated with an excess of 
enzymatic conjugate (2.5 µg mL-1 Str-HRP2) in 500 µL of BSL for 30 min at 30 °C 
under shaking. Finally, the beads were washed twice with BSL, once with BS and 
resuspended in 30 µL of BS. 
For Gli 4 assay, 10 µL of modified magnetic beads were incubated in 1 mL of BS with 
250 nM of biotinylated aptamer and selected amounts of calibration standard (or 20 µL 
of extracted sample) for 30 min at 30 °C in Thermomixer under shaking. After that, the 
beads were washed twice with BSL, and incubated with an excess of enzymatic 
conjugate (2.5 µg mL-1 Str-HRP2) in 1 mL of BSL for 30 min at 30 °C under shaking.  
Finally, the beads were washed twice with BSL, once with BS and resuspended in 10 
µL of BS. 
Amperometric measurement: The resuspended beads (10 µL) were captured on screen 
printed carbon electrodes (Dropsens, Oviedo, Spain) placing a magnet under the 
working electrode, and the electrochemical cell was covered with 40 µL of 3,3’,5,5’-
tetramethylbenzidine + H2O2 substrate. The enzymatic reaction was developed for 30 s 
and the enzymatically obtained product measured by chronoamperometry at 0 V using a 
µ-AutoLab type II potentiostat (Ecochemie, The Netherlands). 
Extractions: For the extraction of flours and no heat-processed foods, 0.8 g of flour or 
homogenised food sample was placed in a 15 mL Falcon tube and washed with an 
aqueous solution of 2 M NaCl. After 20 minutes of shaking at RT, the tube was 
centrifuged in a Heraeus Multifuge 1L-R (ThermoScientific) for 15 min at 7500 g and 
the supernatant was discarded. Prolamins were extracted twice with ethanol 60 % 
solution. For this purpose 4 mL of ethanol solution were added to the tube and the 
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mixture was incubated at RT during 20 min and then centrifuged for 15 min at 7500 g, 
and both supernatants were combined. 
Some food samples were also extracted as follows: 0.25 g of ground sample was mixed 
with 2 mL of cocktail solution (250 mM mercaptoethanol, 2 mM guanidine in 0.1× 
PBS). The suspension was incubated in an oven at 50 ºC for 40 min. Once at room 
temperature, 3 mL of ethanol were added and extraction in a shaker was extended for 1 
hour. Finally the samples were centrifuged for 30 min at 2500 g, and the supernatant 
was used in the analysis. The sample containing chocolate was extracted in the presence 
of 0.25 g of gelatin and 0.1 g of polyvinypyrrolidone, which were added to 0.25 g of 
ground sample before the extraction.  
 
3. Results and discussion 
We chose a competitive assay format, well suited to detect both intact protein and small 
protein fragments, using two previously selected aptamers targeting the immunotoxic 
α2-gliadin fragment, 33-mer [15]. Magnetic microparticles are employed as support for 
the sensing phase to take advantage of the efficient magnetic separation offered by this 
platform, which facilitates subsequent exhaustive washing steps thus minimizing major 
problems associated with non-specific interactions. The preparation of the sensing phase 
is very simple. A commercially available 33-mer, modified at its carboxy-terminus with 
a biotin, is immobilized onto the surface of streptavidin-modified magnetic particles and 
then the unoccupied sites of streptavidin are blocked with biotin. The analytical assay 
we developed using this platform comprises the following steps (Figure 1): first, the 
sample and the biotin-labelled aptamer are incubated with a fixed amount of the 
modified magnetic beads. In this step, the analyte from the test solution competes with 
the immobilized peptide for a limited amount of aptamer. As a result, part of the biotin-
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aptamer is specifically captured and separated from the sample after applying an 
external magnetic field. In order to detect the bound aptamer, particles are incubated in 
a second step with a streptavidin-peroxidase conjugate containing two molecules of 
enzyme per streptavidin as reporter molecule. Finally, the enzyme activity on the 
surface is electrochemically quantified by magnetically entrapping the modified beads 
onto a screen-printed carbon electrode. After the addition of tetramethylbenzidine and 
hydrogen peroxide we measured by chronomaperometry the reduction of the product 
enzymatically produced. The higher the concentration of gliadin in the sample is the 
lower the reduction current we obtain. 
Figure 1. 
3.1. Assay Optimization 
To obtain optimal conditions for the competitive assay, the concentration of biotin-
aptamer was first selected, fixing the amount of magnetic particles modified with the 
peptide in 0.06 mg mL-1. In this study, different concentrations of the aptamers in the 
range 0.5 nM-2µM were tested without protein or peptide in solution. This analysis 
produces typical binding curves for both aptamers (Figure 2). 250 nM of aptamer, the 
concentration that yield around 50% of the maximum obtained signal, was selected for 
competition. In the absence of the aptamers, we observe only a small reduction current 
(0.4 ± 0.1 µA), which confirmed that the contribution of the nonspecific interaction of 
Str-HRP2 conjugate is not significant. The assay also gives negligible responses when it 
is performed using a randomized biotinylated DNA library at a 250 nM concentration 
level. Conversely, we registered a maximum signal value of 4.7± 0.1 µA and 3.6±0.1 
µA for Gli 4 and Gli 1, respectively at this aptamer concentration. These results are 
consistent with the specific interaction of both aptamers with the immobilized peptide 
and a higher affinity for the aptamer Gli 4 [15].  
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Figure 2 
The second variable we took into consideration is the composition of the competition 
buffer. To evaluate the effect of ethanol in the aptamer/peptide interaction, we 
performed the competitive assay in buffer containing different concentrations of this 
alcohol. The presence of 1.2% of ethanol, which will correspond to a 1:50 dilution of 
samples extracted using 60 % ethanol, increases the maximum signal obtained while the 
blank is not affected. The improved signal amplitude at 1.2% ethanol can be explained 
given the apolar nature of the peptide modifying the surface of the beads, which may 
cause their slight aggregation. A small amount of ethanol may act as disaggregating 
agent, favouring the aptamer/peptide interaction. Consistent with this, the competitive 
assay achieves improved signal decrease with this amount of ethanol in the buffer. At 
3% of ethanol the binding of Gli 1 to the peptide decreases to about 35% of the 
maximum while Gli 4 interaction is less affected, which again is in agreement with the 
lower affinity constant for the peptide-Gli 1 reaction. 
Therefore, the best performance in terms of sensitivity is obtained employing 0.06 mg 
mL-1 of the modified beads and 250 nM aptamer, in the presence of 1.2% ethanol. Upon 
the addition of 10 µg L-1 of PWG standard to the competition buffer in the presence of 
Gli 1, a 13% of signal decrease is observed with a coefficient of variation of 6%. Under 
the same conditions, Gli 4 gives rise to higher sensitivity with about 20% of decrease at 
the same concentration of PWG. We find, however, that this aptamer leads to worse 
reproducibility, more than 15% of RSD at 10 µg L-1, probably related to the fact that a 
higher tendency of the 33-mer-modified magnetic particles to aggregate is observed 
with this aptamer. To overcome this difficulty we performed the competitive assay with 
Gli 4 using a higher dilution of the magnetic beads during the competition i.e 0.01 mg 
mL-1, while maintaining the amount of beads on the electrode surface for measurement 
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(10 µg). In this way sensitivity of the assay was not affected and precision was 
improved, with a RSD of 6% for 10 µg L-1 of PWG. 
 
3.2. Analytical performance 
The performance of both aptamers in competitive assays under the optimum conditions 
was compared using PWG gliadin or 33-mer peptide as standards. The selection of the 
standard in order to obtain a calibration to which refer the measurements of the samples 
have to be carefully done to avoid deviations in the value obtained. Most used 
calibration and validation standard is PWG gliadin, a material obtained after processing 
of 28 different cultivars of wheat [16]. We used this material as a gliadin standard to 
obtain the calibration curve. 
In Figure 3A, the current intensities obtained after challenging the modified beads with 
increasing concentrations of PWG using both aptamers is depicted. As expected, 
aptamer Gli 4 gives rise to higher currents than aptamer Gli 1 as a result of the 
difference in affinity. 
Data were fitted to a four parameters logistic (equation 1) 
y = A + 	

 
                           (1) 
where A is the response at an infinite concentration of analyte, B is the response at a 
zero concentration of analyte, EC50 is the concentration of analyte that corresponds to 
the 50 % of the maximum signal and p is the Hill slope that represents the slope at the 
inflexion point of the sigmoidal curve. Due to the low solubility of gliadin in aqueous 
solution concentrations higher than 1 µg L-1 were not assayed, which precluded the 
observation of the complete sigmoidal curve. The best fitting were obtained fixing A 
parameter to zero and the equations are the following: 
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I(µA)= (3.60)/(1+([PWG (µg L-1)])/721)0.5); r =0.980 for Gli 1 and 
I(µA)=(5.17)/(1+([PWG (µg L-1)]/273)0.6); r= 0.997 for Gli 4. 
The limit of detection of each assay was calculated as the concentration that gives the 
95 % of the maximum signal and corresponds to 4.9 µg L-1 of gliadin when using Gli 1 
as recognition element and 0.5 µg L-1 of gliadin when using Gli 4. Taking into account 
the sample extraction, the dilution of the extract and the gliadin to gluten ratio, the limit 
of detection in real samples can be calculated in order to verify whether the methods 
meet the requirements to evaluate the accomplishment of the EU legislation. The overall 
sample dilution is 1:500 and the content of gliadin in gluten is considered as 50 %, [17] 
though values ranging from 32% to 67 % have been found [18], so the limit of detection 
expressed in gluten for each assay is 4.9 ppm and 0.5 ppm for Gli 1 and Gli 4, 
respectively. Those values are below the limits needed to check the legislation 
accomplishment and are similar or slightly lower than competitive immunoassays even 
those currently marketed [4,11,19-21]. 
Figure 3 
The repeatability of the assays calculated as the coefficient of variation at 1 and 10 µg 
L-1 of gliadin concentration were 7 and 8%, respectively for Gli 1 aptamer and 9 and 6 
%, respectively for Gli 4. The inter assay reproducibility, calculated with the signal 
obtained for 10 µg L-1 in three different days is 9.5 % for Gli 1 assay and 6% for Gli 4 
assay. 
Competitive assays are specifically designed for hydrolysed samples where the proteins 
are digested to small peptides containing a single epitope for the antibody. The 
competitive format of R5 antibody uses a peptide fragment (QQPFP) as a standard even 
though the equivalence between peptide fragments and the intact protein is lacking [13]. 
This precludes the conversion of the results into gluten content as required in the 
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legislation [17]. On the contrary, the competitive G12 assay uses the intact protein [11].  
We have previously found a correlation between Sigma gliadin and 33-mer using G12 
antibody in an electrochemical competitive immunoassay [20]. Therefore, the feasibility 
of using 33-mer peptide as a standard for the competitive apta-assay was studied. In 
Figure 3B, the response of Gli 1-based method to increasing concentrations of 33-mer 
is shown and compared with the calibration plot using PWG both expressed in nM. It is 
apparent that the aptamer recognizes the peptide but at much larger concentrations than 
the intact protein, which indicates that PWG contains several binding sites in its 
structure. However, the number of those “aptatopes” would be very high, about 200, 
which seems unrealistic. In our previous work two binding sites for the antibody G12 
were found in each gliadin standard, which is reasonable. Recently, we have found that 
Gli 1 exhibits positive cooperativity when binding to PWG, which can explain the 
apparent higher affinity towards the intact protein even taking into consideration the 
presence of several binding sites [22].  
On the contrary, proper calibration plots using Gli 4 aptamer as recognition element and 
33-mer peptide as standard were not obtained. This fact is attributed to microscopic 
aggregation of the beads in presence of this aptamer. Therefore, Gli1 aptamer was 
selected as the receptor for subsequent testing of hydrolysed samples.  
The response of Gli 1 aptamer to the recognition epitope of the official R5 method, that 
is, the pentapeptide QQPFP [23] was also tested. This specific sequence is not present 
in the immunodominat 33-mer peptide used for aptamer selection but it is present in 
wheat, rye and barley prolamins. The aptamer was able to recognize this peptide but at 
much higher concentrations than 33-mer (above 1µM), which suggests a much lower 
affinity accordingly to its absence in the selection target. 
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3.3. Cross-reactivity against other cereals and grains 
Not only wheat proteins are toxic for coeliac disease patients, prolamins from barley 
and rye have almost the same toxicity. However, the toxicity of oat for coeliac patients 
is still controversial [24]([25] and citation therein), so oat prolamins also have to be 
evaluated towards the quantification of the toxicity in food products. For this reason it is 
necessary to evaluate the response of the competitive assays using Gli 1 and Gli 4 
aptamers against prolamins from other toxic cereals and the selectivity against not-CD-
triggering cereals and grains. Because of the unavailability of prolamin standards or 
reference materials from other grains, the ethanol-soluble fraction was extracted from 
each grain flour. After the extraction, the total protein present in solution was quantified 
by the Bradford method using PWG as standard, obtaining a content in prolamin for 
each extract as follows: wheat 5.4 mg mL-1, rye 4.6 mg mL-1, barley 5.2 mg mL-1 and 
oat 4.7 mg mL-1. All the extracts were diluted at different levels to obtain the desired 
protein concentration in the competition buffer. As it can be seen in Figure 4 both 
assays with Gli 1 and Gli 4, recognise gliadins (wheat), hordeins (barley) and secalins 
(rye) in a similar extension within the experimental error. However, the response to 
avenins (oat) is different. Gli 1 aptamer is not able to bind oat proteins while Gli 4 
aptamer recognises avenins but with less affinity than the rest of prolamins from CD 
toxic cereals. This result is interesting because the antibodies G12 and A1, also raised 
against the 33-mer peptide, weakly binds to avenins although 33-mer is not present in 
their sequence [26]. The sensitivity order to prolamins was, however, different: 
hordenins ≈ gliadins > secalins >> avenin for G12 and hordeins ≈  rye > gliadin >> 
avenins for the aptamers. In our case, differences between hordeins, gliadins and 
secalins are less pronounced in both cases. The official R5 method does not respond to 
the controversial oat prolamins [10].  
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Figure 4 
It is also important to ensure the non-response of the developed method against proteins 
from non-toxic flours such as soya, maize and rice often used as substitutes of toxic 
cereals to elaborate CD-safe food. To evaluate the cross-reactivity, the response to 
increasing concentrations of proteins extracted from soya, maize and rice flours were 
assayed. In all concentration range, the analytical responses expressed as current 
percentage of the maximum current obtained in the absence of protein were around 
100%. Specifically, percentages obtained with Gli 1 assay were: soya 112±11 % maize 
135±26 % and rice 112±9 %. For the Gli 4 assay were: soya 125±37 %, maize 121±36 
% and rice 113±25 %. According to this, aptamers do not cross react with non-toxic 
proteins. 
 
3.4. Application of the competitive assays to food samples 
The competitive methods developed are sensitive and selective enough to be applied to 
gluten determination in gluten free labelled foods in order to evaluate the compliance with 
the law and to provide more information to the consumer. To do this, we tested samples 
provided by two external laboratories. All of them had unknown gluten content. The 
samples provided by Laboratory I were divided, according to the information given by the 
company, in two groups: non-hydrolysed (Table 1) to be quantified by the Gli 4 assay that 
is more sensitive, and hydrolysed samples (Table 2) to be quantified by Gli 1 assay, the 
peptide- responsive one. Liquid samples were just diluted with 60% ethanol and solid 
samples were extracted with the conventional extraction procedure using 60% ethanol, 
which is the method recommended by the commercial kit based on G12, the antibody used 
by the company for comparison. Samples are considered as positive when the gluten 
content is above the limit of quantification of the method used in each case, even in cases 
where samples meet gluten free specifications (less than 20 ppm gluten). 
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Samples identified as positive with the reference methods are in general positive with our 
method. There are two apparent exceptions, both liquid non-hydrolysed samples (liquids C 
and H). These are gluten free samples that were spiked with gluten by the external 
laboratory in a blind assay. The recovery values we found for these samples are close 100% 
even in the case of sample C, spiked with a gluten concentration very near to the limit of 
quantification of our method. So we can conclude that our method does not present false 
negative results. Only one out of the 5 liquid non-hydrolysed samples analysed (liquid A) 
was negative by the G12 immunoassay. In this sample our method detected gluten but with 
a content below the 20 ppm threshold level. This difference may be due to the improved 
sensitivity of our method with respect to G12. Gliadin levels measured in the solid non-
hydrolysed samples were comparable with levels detected by G12 assay in 50 % of samples 
(3 out of 6). Both methods showed non-detectable gluten in a rice sample. In general, our 
method detects higher gluten content than did the G12 kit. Interestingly, the three discordant 
samples are negative by G12-assay, and positive by our method. These differences can be 
explained by variations in the extracted target compounds detected by the two assays.  
Attending to the results for hydrolysed samples (Gli 1 assay, Table 2), there is a good 
correlation between the results provided by the external analysis and those obtained using 
the competitive assay developed in this work. This correlation demonstrates the 
applicability of the competitive assay based on the aptamer Gli 1 to quantify gluten in 
hydrolysed samples. Only a false positive result was obtained, corresponding to a sample of 
a gluten free beer. It is accepted that samples where the gluten content differ most are the 
hydrolysed ones because the value obtained strongly depends on the target sequence 
detected [27]. In a previous study, hordein content in gluten was comparatively assessed 
using ELISA and MS [28]. This study reveals significant differences between both 
methods, showing that 10% of the tested beers give ELISA gluten contents below the limit 
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of quantification but near average hordein content by MS. Our assay, using an aptamer 
that detects hordeins [15], could be an alternative for this kind of samples. 
Solid samples provided by Laboratory II (Table 3) were extracted alternatively with the 
conventional 60% aqueous ethanol extraction method and with cocktail solution to evaluate 
the influence of reducing and denaturing agents on our method. The results were compared 
with values obtained with the official method (R5) provided by the company after carrying 
out the analysis with the Gli 4 competitive method and with an independent analysis 
performed by a certified Spanish company for gluten analysis (Laboratory III). Most of the 
values obtained with R5 antibody were comparable with those obtained with our method 
after ethanol extraction except for cappuccino, where a false positive result is observed. 
Again, this is probably due to the increased sensitivity of our method. The influence of the 
cocktail solution on the aptamer-based competitive method was studied. In general higher 
results were obtained with the cocktail solution, probably because a larger yield of the 
extraction. The exception was the sample containing chocolate, even though PVP and fish 
gelatin were used to assist the extraction. It is remarkable the discrepancy between the 
analysis using the same procedure, which is an indication of the difficulty of such samples. 
Additional discrepancies are observed in corn flakes samples which would led to labelling 
as gluten free according to one of the laboratories but not to the other. Our results with 
ethanol extraction are in agreement with laboratory II and are closer to laboratory III after 
cocktail extraction for one of them. Therefore, it can be concluded that the alteration of the 
protein conformation during the extraction procedure does not significantly affect its 
recognition by the aptamer (no false negative detected) and the cocktail solution is 
compatible with our aptamer-based competitive method unlike competitive immunoassays.  
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4. Conclusions 
The combination of magnetic beads and aptamers as receptors has proved to be an 
attractive method for the sensitive quantification of gluten, with a detection limit of 0.5 
ppm in the case where the aptamer (Gli 4) with the highest binding affinity to the 
protein is employed, and 4.9 ppm when using Gli 1, the most abundant aptamer. The 
assays can quantify gluten in food samples below the legally established limits for the 
labelling of “gluten free” products. Gli 4-based method is compatible with cocktail 
extraction method, allowing the quantification of gluten in heated foods. The assay 
using Gli 1 aptamer can quantify gluten in hydrolysed samples. Both methods are 
complementary and can be valuable tools in the determination of gluten in foods 
intended for coeliac patients. 
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TABLES 
 
Table 1: Samples extracted with ethanol 60 % and analysed with Gli4 aptamer. They 
were compared with a G12 method carried out by the external laboratory  
 
Sample 
Gli 4 method 
(ppm gluten) 
External Laboratory I 
(ppm gluten) 
Millet flour  16 ± 2 15 
Quinoa 76 ± 24 40 
Maize flour 35 ± 20 Negative  
Rice flour  < LOD Negative 
Chamtor sample  36 ± 25 Negative 
Almond flour  116 ± 65 Negative 
Liquid sample A 12 ± 1 Negative 
Liquid sample B 30 ± 13 Positive 
Liquid sample C 1 ± 0.6 Positive 
Liquid sample G 35 ± 7 Positive 
Liquid sample H  16 ± 5  Positive  
 
 
 
 
 
 
 
Page 19 of 32 Analytical & Bioanalytical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
20 
 
Table 2: Analysis of liquid hydrolysed samples by the Gli 1 based competitive method 
and comparison with the values provided by the external laboratory. 
 
Sample 
Competitive Gli 1 
(ppm gluten) 
 External 
Laboratory I 
Wheat beer (Paulaner) 224 ± 5  Positive 
Liquid sample D 46 ± 6  Dubious 
Liquid sample E 92 ± 29  Positive 
Spanish beer (Cruzcampo) 130 ± 27  Positive 
Liquid sample F 130 ± 28  Positive 
Daura Beer (gluten free) 113 ± 36  Negative 
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Table 3: Samples analysed with the assay using Gli 4 aptamer after two different 
extraction protocols and compared with R5 method carried out by two independent 
laboratories. 
 
Sample ethanol extraction  
(ppm gluten) 
cocktail 
extraction  
(ppm gluten) 
Lab II 
(ppm 
gluten) 
Lab III 
(ppm 
gluten) 
 
Cake >100 >100 78 >80  
Fixamyl 8 ± 3 30 7 13.3 ± 1.1  
Capuccino 23 ± 3 50 <5 <5  
Rolled oats 63 ± 9 97 ± 9 77 >80  
Corn flakes 2 34 58 ± 4 38 18.1 ± 1.3  
Dessert Chocolate 11 <LD 13 <5  
Fit snack 81 ± 8 90 77 >80  
Vanilla cream <6 <LD <5 <5  
Corn flakes 1 13 34 ± 7 17 30.8 ± 1.9  
Panna Cotta 6 ± 1 < LD <5 <5  
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CAPTION FOR THE FIGURES 
 
Figure 1: Schematic representation of the competitive aptamer-based assay for gliadin 
determination. 
 
Figure 2: Binding curves of aptamers Gli 4 (•, dashed line) and Gli 1 (□, solid line) to 
33-mer-peptide immobilized onto magnetic beads through biotin-estreptavidin 
interaction. 
 
Figure 3: Calibration curves for the competitive assay: (A) using Gli 4 (•, dashed line) 
and Gli 1 (□, solid line) aptamers with PWG gliadin as a standard (B) using Gli 1 
aptamer with PWG gliadin (□, solid line) and 33-mer peptide (•, dashed line) as 
standards. 
 
Figure 4: Response of the competitive assay expressed as percentage of the maximum 
signal obtained in the absence of protein to different toxic prolamins from wheat (♦, red 
line), rye (■, blue line), barley (•, green line), and oats (□, black line) using (A) Gli 1 
and (B) Gli 4 aptamers. 
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